4//SEC Filing
FIVE PRIME THERAPEUTICS INC 4
Accession 0001209191-17-009269
CIK 0001175505operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:18 PM ET
Size
9.6 KB
Accession
0001209191-17-009269
Insider Transaction Report
Form 4
Baker Kevin Paul
SVP, Development Sciences
Transactions
- Award
Common Stock
2017-02-07+5,625→ 88,389 total - Award
Employee Stock Option (right to buy)
2017-02-07+25,000→ 25,000 totalExercise: $45.38Exp: 2027-02-06→ Common Stock (25,000 underlying) - Award
Common Stock
2017-02-07+7,031→ 95,420 total
Footnotes (4)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 5, 2018, 2019 and 2020, provided the reporting person provides services to Five Prime Therapeutics, Inc. through each such date.
- [F2]Includes 264 shares of common stock granted to the reporting person by Five Prime Therapeutics, Inc. pursuant to a company match under Five Prime Therapeutics, Inc.'s 401(k) plan.
- [F3]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on February 5, 2019 and two-thirds (2/3) of the restricted stock will vest on February 5, 2020, provided the reporting person provides services to Five Prime Therapeutics, Inc. through each such date.
- [F4]The shares underlying the option vest at a rate of one forty-eighth (1/48th) per month beginning on March 7, 2017, provided the reporting person provides services to Five Prime Therapeutics, Inc. through each such date.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175505
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 7:18 PM ET
- Size
- 9.6 KB